Study unlocks key mechanisms that determine acquired resistance to immunotherapy in advanced melanoma
For the first time, researchers have identified mechanisms that determine how advanced melanoma can become resistant to immune checkpoint inhibitors, a discovery that could lead to the development of new and improved treatments for the deadliest type of skin cancer.
Leave a Reply